India has reported a coronavirus infection 259,551 in the last 24 hours, with 4,209 deaths and an increase in the number of cases of mucormycosis, a fungal infection also known as “black fungus”, and further treatment.
The number of infections in South Asia has risen to 26.03 million, with 291,331 deaths, according to the Ministry of Health on Friday.
“Black mushroom” presents a new challenge for COVID-19 patients on steroid therapy as well as those with pre-existing diabetes.
It causes blisters or runny nose, blurred vision or blurred vision, chest pain, shortness of breath and coughing up blood.
Doctors believe that the use of steroids in the severe treatment of COVID-19 may contribute to the problem. Coronavirus patients with diabetes and weakened immune systems are prone to attacks.
Many of the drugs used to fight coronavirus suppress the immune system, which often prevents fungal infections.
The government sends attention to the countries
India’s Ministry of Health on Thursday called on state authorities to declare it a “known disease” according to the Epidemics Act, meaning it must identify and monitor everything.
The government’s warning is that teams rebuilt by surgeons and specialists in ear, nose, and throat special programs should be prepared to help the growing number of patients.
India has also ordered emergency measures to prevent the spread of rare diseases among coronavirus patients.
Gujarat and Telangana said Thursday they were the last to announce the black fungal epidemics, just one day from Rajasthan.
The state of Maharashtra has reported more than 2,000 cases. Gujarat, the government of Prime Minister Narendra Modi, has about 1,200 members, officials said.
Ahmedabad State Hospital, one of the largest in Gujarat, treats 371 cases, according to a spokesman. Health officials say there are about 400 cases in a state hospital in Rajkot city.
New Delhi has set up special rooms in three hospitals to deal with the growing number of black mushrooms.
There are more than 200 black fungus patients in New Delhi hospitals, with more on the waiting list, according to media reports.
The IT headquarters in Bangalore opened special rooms Wednesday that filled within a few hours, doctors said.
India typically catches at least 20 cases of “black fungus” a year, but the disease is a threat from the coronavirus that has killed 120,000 people in the past six weeks.
Although authorities do not say how many people died from the fungus, the disease kills more than 50 percent of patients within a few days. In some cases doctors perform surgeries to save their lives.
Anti-fungal drugs and the recent decline affecting India’s healthcare system and the media have been filled with requests from their relatives with mucormycosis asking for help to find a cure.
Black fungus is caused by organisms called mucormycetes, which can enter the body through respiration or injury to the skin.
These are naturally found in soil and decaying materials, but when found in humans, they can infect air sacs behind the forehead, nose, cheeks and middle of the face and teeth.
Some doctors say there has been a fearful use of steroids against COVID-19 which has contributed to the spread of black fungus.
“The careless use of steroids in the treatment of COVID-19 patients should be avoided,” Maharashtra Health Minister Rajesh Tope said on Wednesday.
Some doctors say that poor hygiene in some hospitals by placing coronavirus patients on oxygen glasses has caused black fungi to infect.